DiaMedica Therapeutics (DMAC) Non Operating Income (2018 - 2025)

DiaMedica Therapeutics (DMAC) has reported Non Operating Income for 8 consecutive years, with $483000.0 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Non Operating Income fell 8.52% year-over-year to $483000.0; the trailing twelve-month figure through Dec 2025 stood at $1.7 million (down 26.69% YoY), and the FY2025 full-year result was $1.7 million, down 26.82% from the prior year.
• Non Operating Income climbed to $483000.0 in Q4 2025 per DMAC's latest filing, from $419000.0 in the prior quarter.
• Across five years, Non Operating Income topped out at $709000.0 in Q4 2023 and bottomed at -$27000.0 in Q3 2021.
• Historically, Non Operating Income has averaged $291666.7 across 5 years, with a median of $263500.0 in 2023.
• The sharpest annual moves came in 2021 and 2022: Non Operating Income sank 121.09% in 2021, then soared 3171.43% in 2022.
• Over 5 years, Non Operating Income stood at $7000.0 in 2021, then jumped by 3171.43% to $229000.0 in 2022, then surged by 209.61% to $709000.0 in 2023, then slipped by 25.53% to $528000.0 in 2024, then retreated by 8.52% to $483000.0 in 2025.
• According to Business Quant data, Non Operating Income over the past three periods registered $483000.0, $419000.0, and $314000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.